Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Uterine bleeding Age: Adult |
Dose: Oral – 5-10 mg Frequency: once daily Duration: 5-10 days Note: Beginning day 16 or 21 of the menstrual cycle; withdrawal bleeding may be expected within 3 to 7 days after discontinuing medroxyprogesterone. |
|
Indication: Amenorrhea, secondary Age: Adult |
Dose: Oral – 5-10 mg Frequency: once daily Duration: 5-10 days Note: May be started at any time; withdrawal bleeding may be expected within 3-7 days after discontinuing medroxyprogesterone. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: NO_HEADER – No approved pediatric dosage available Note: No approved pediatric dosage available |
Administration
- Can be taken with or without food
- Take with meals if upset stomach
Side Effect
- Amenorrhea
- Breakthrough bleeding
- Change in menstrual flow
- Spotting
- Edema
- Anorexia
- Weakness
- Pain at injection site
- Angioedema
- Change in weight
- Depression
- Dizziness
- Headache
- Nervousness
- Somnolence
- Breast tenderness
- Galactorrhea
- Abdominal pain
- Nausea and vomiting
- Cholestatic jaundice
- Deep vein thrombosis (DVT) (DVT)
- Thrombophlebitis
- Thrombophlebitis and pulmonary embolism
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Aminoglutethimide, enzyme-inducing drugs (e.g. carbamazepine, griseofulvin, phenobarbital, rifampicin, phenytoin)
|
May reduce plasma concentrations leading to reduced efficacy
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Thromboembolic disorders
|
Risk of blood clots
|
|
Hormone-dependent carcinoma
|
May stimulate tumor growth
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.